Literature DB >> 18004566

Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation.

Jong Myun Park1, Masaki Terabe, Debra D Donaldson, Guido Forni, Jay A Berzofsky.   

Abstract

INTRODUCTION: We and others previously observed immunosurveillance against transplantable tumors in mice, and enhancement thereof by blockade of negative regulation by T reg cells or the NKT-IL-13-myeloid cell-TGF-beta regulatory circuit. However, it was unknown whether natural immunosurveillance inhibits growth of completely spontaneous autochthonous tumors, and whether it can be improved by inhibition of negative regulation.
MATERIALS AND METHODS: To examine the existence of T cell-mediated immunosurveillance against spontaneous tumors, BALB-neuT mice were treated with anti-CD4 and/or anti-CD8. A role for IL-13 in the suppression of immunosurveillance was investigated by treating mice with IL-13 inhibitor.
RESULTS: We show that even spontaneous autochthonous breast carcinomas arising in Her-2/neu transgenic mice appear more quickly when the mice are depleted of T cells, evidence for T-cell mediated immunosurveillance slowing tumor growth. This immunosurveillance could be further enhanced by blockade of IL-13 (but not IL-4) which slowed the appearance of these autologous tumors compared to control antibody-treated mice.
CONCLUSION: Thus, even completely spontaneous, autochthonous breast cancers can be controlled in part by natural immunosurveillance, and blockade of negative regulation can improve this control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004566     DOI: 10.1007/s00262-007-0414-0

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  11 in total

Review 1.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

2.  Gene Therapy against Murine Melanoma B16F10-Nex2 Using IL-13Ralpha2-Fc Chimera and Interleukin 12 in Association with a Cyclopalladated Drug.

Authors:  Flavia Hebeler-Barbosa; Elaine G Rodrigues; Rosana Puccia; Antonio Cf Caires; Luiz R Travassos
Journal:  Transl Oncol       Date:  2008-09       Impact factor: 4.243

Review 3.  Manipulation of Innate Immunity for Cancer Therapy in Dogs.

Authors:  Daniel Regan; Steven Dow
Journal:  Vet Sci       Date:  2015-12-01

4.  Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation.

Authors:  Alexander Pedroza-Gonzalez; Kangling Xu; Te-Chia Wu; Caroline Aspord; Sasha Tindle; Florentina Marches; Michael Gallegos; Elizabeth C Burton; Daniel Savino; Toshiyuki Hori; Yuetsu Tanaka; Sandra Zurawski; Gerard Zurawski; Laura Bover; Yong-Jun Liu; Jacques Banchereau; A Karolina Palucka
Journal:  J Exp Med       Date:  2011-02-21       Impact factor: 14.307

5.  Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.

Authors:  Sin Mun Tham; Kee Hui Ng; Sim Hwee Pook; Kesavan Esuvaranathan; Ratha Mahendran
Journal:  Clin Dev Immunol       Date:  2011-10-13

6.  DNA vaccination against oncoantigens: A promise.

Authors:  Manuela Iezzi; Elena Quaglino; Augusto Amici; Pier-Luigi Lollini; Guido Forni; Federica Cavallo
Journal:  Oncoimmunology       Date:  2012-05-01       Impact factor: 8.110

7.  The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models.

Authors:  Sirus Palsson; Timothy P Hickling; Erica L Bradshaw-Pierce; Michael Zager; Karin Jooss; Peter J O'Brien; Mary E Spilker; Bernhard O Palsson; Paolo Vicini
Journal:  BMC Syst Biol       Date:  2013-09-28

Review 8.  Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.

Authors:  Laura Conti; Roberto Ruiu; Giuseppina Barutello; Marco Macagno; Silvio Bandini; Federica Cavallo; Stefania Lanzardo
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

9.  Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?

Authors:  Lin Xiao; Xin Yu; Rong Zhang; Hui Chang; Shaoyan Xi; Weiwei Xiao; Zhifan Zeng; Huizhong Zhang; Ruihua Xu; Yuanhong Gao
Journal:  Oncotarget       Date:  2016-06-07

10.  Immunological effects of chemotherapy in spontaneous breast cancers.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Laurence Zitvogel
Journal:  Oncoimmunology       Date:  2013-11-14       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.